galectin-3 inhibitor (Galecto Biotech)

N/A

Report date: 2025/01/26 17:23:09
NME

Base Information

Drug Namegalectin-3 inhibitor (Galecto Biotech)
Drug Alias NameGal-200GAL-200-10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsOcular fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalecto Biotech AB
China Registration ClassN/A

Develop Information

Active CompaniesGalecto Biotech AB
Inactive CompaniesN/A
Active IndicationsOcular fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A